DXI 9000 Access Immunoassay Analyzer
Device Devices
General payments
$315,744
Research payments
$5,219,269
Through program year 2025, $315,744 in general payments and $5,219,269 in research payments were reported against DXI 9000 Access Immunoassay Analyzer (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $33,479 | 12 |
| 2025 | Research | $780,986 | 9 |
| 2024 | General | $275,629 | 27 |
| 2024 | Research | $133,206 | 2 |
| 2023 | General | $48 | 1 |
| 2023 | Research | $38,390 | 12 |
| 2022 | General | $6,588 | 9 |
| 2022 | Research | $4,266,686 | 53 |
Breakdown
The top 5 of 7 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
49 general · 76 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.